- Home
- EVGO vs BNTC Comparison
EVGO vs BNTC Comparison
Compare EVGO & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGO
- BNTC
- Stock Information
- Founded
- EVGO 2010
- BNTC 1995
- Country
- EVGO United States
- BNTC United States
- Employees
- EVGO N/A
- BNTC N/A
- Industry
- EVGO Other Specialty Stores
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- EVGO Consumer Discretionary
- BNTC Health Care
- Exchange
- EVGO Nasdaq
- BNTC Nasdaq
- Market Cap
- EVGO 376.5M
- BNTC 366.6M
- IPO Year
- EVGO N/A
- BNTC N/A
- Fundamental
- Price
- EVGO $3.73
- BNTC $11.47
- Analyst Decision
- EVGO Strong Buy
- BNTC Strong Buy
- Analyst Count
- EVGO 10
- BNTC 6
- Target Price
- EVGO $6.00
- BNTC $23.83
- AVG Volume (30 Days)
- EVGO 4.8M
- BNTC 208.6K
- Earning Date
- EVGO 07-31-2025
- BNTC 05-14-2025
- Dividend Yield
- EVGO N/A
- BNTC N/A
- EPS Growth
- EVGO N/A
- BNTC N/A
- EPS
- EVGO N/A
- BNTC N/A
- Revenue
- EVGO $276,954,000.00
- BNTC N/A
- Revenue This Year
- EVGO $41.18
- BNTC N/A
- Revenue Next Year
- EVGO $33.63
- BNTC N/A
- P/E Ratio
- EVGO N/A
- BNTC N/A
- Revenue Growth
- EVGO 45.15
- BNTC N/A
- 52 Week Low
- EVGO $2.20
- BNTC $6.91
- 52 Week High
- EVGO $9.07
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- EVGO 44.84
- BNTC 32.18
- Support Level
- EVGO $3.68
- BNTC $13.60
- Resistance Level
- EVGO $4.10
- BNTC $15.62
- Average True Range (ATR)
- EVGO 0.27
- BNTC 1.30
- MACD
- EVGO -0.09
- BNTC -0.41
- Stochastic Oscillator
- EVGO 7.69
- BNTC 0.52
About EVGO EVgo Inc.
EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.